activacin for injection 12 million [acute myocardial infarction] (アクチバシン注1200万[急性心筋梗塞])
kyowa kirin co.,ltd - alteplase (genetical recombination) - injection
activacin for injection 12 million [acute phase of ischemic cerebrovascular disorder] (アクチバシン注1200万[虚血性脳血管障害急性期])
kyowa kirin co.,ltd - alteplase (genetical recombination) - injection
activacin for injection 24 million [acute myocardial infarction] (アクチバシン注2400万[急性心筋梗塞])
kyowa kirin co.,ltd - alteplase (genetical recombination) - injection
activacin for injection 24 million [acute phase of ischemic cerebrovascular disorder] (アクチバシン注2400万[虚血性脳血管障害急性期])
kyowa kirin co.,ltd - alteplase (genetical recombination) - injection
activacin for injection 6 million [acute myocardial infarction] (アクチバシン注600万[急性心筋梗塞])
kyowa kirin co.,ltd - alteplase (genetical recombination) - injection
activacin for injection 6 million [acute phase of ischemic cerebrovascular disorder] (アクチバシン注600万[虚血性脳血管障害急性期])
kyowa kirin co.,ltd - alteplase (genetical recombination) - injection
grtpa injection 12 million [acute ischemic cerebrovascular syndrome] (グルトパ注1200万[虚血性脳血管障害急性期])
mitsubishi tanabe pharma corporation - alteplase (genetical recombination) - injection
grtpa injection 12 million [acute myocardial infarction] (グルトパ注1200万[急性心筋梗塞])
mitsubishi tanabe pharma corporation - alteplase (genetical recombination) - injection
grtpa injection 24 million [acute ischemic cerebrovascular syndrome] (グルトパ注2400万[虚血性脳血管障害急性期])
mitsubishi tanabe pharma corporation - alteplase (genetical recombination) - injection
grtpa injection 24 million [acute myocardial infarction] (グルトパ注2400万[急性心筋梗塞])
mitsubishi tanabe pharma corporation - alteplase (genetical recombination) - injection